vs

Side-by-side financial comparison of AVIENT CORP (AVNT) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

AVIENT CORP is the larger business by last-quarter revenue ($760.6M vs $719.4M, roughly 1.1× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 2.2%, a 71.0% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs 1.9%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $125.4M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -4.2%).

Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

AVNT vs DOC — Head-to-Head

Bigger by revenue
AVNT
AVNT
1.1× larger
AVNT
$760.6M
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+1.2% gap
DOC
3.1%
1.9%
AVNT
Higher net margin
DOC
DOC
71.0% more per $
DOC
73.2%
2.2%
AVNT
More free cash flow
DOC
DOC
$231.6M more FCF
DOC
$357.0M
$125.4M
AVNT
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-4.2%
AVNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVNT
AVNT
DOC
DOC
Revenue
$760.6M
$719.4M
Net Profit
$16.9M
$114.0M
Gross Margin
30.2%
Operating Margin
5.2%
17.4%
Net Margin
2.2%
73.2%
Revenue YoY
1.9%
3.1%
Net Profit YoY
-65.0%
2406.4%
EPS (diluted)
$0.18
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNT
AVNT
DOC
DOC
Q4 25
$760.6M
$719.4M
Q3 25
$806.5M
$705.9M
Q2 25
$866.5M
$694.3M
Q1 25
$826.6M
$702.9M
Q4 24
$746.5M
$698.0M
Q3 24
$815.2M
$700.4M
Q2 24
$849.7M
$695.5M
Q1 24
$829.0M
$606.6M
Net Profit
AVNT
AVNT
DOC
DOC
Q4 25
$16.9M
$114.0M
Q3 25
$32.6M
$-117.1M
Q2 25
$52.6M
$31.7M
Q1 25
$-20.2M
$42.8M
Q4 24
$48.3M
$4.5M
Q3 24
$38.2M
$85.9M
Q2 24
$33.6M
$146.0M
Q1 24
$49.4M
$6.7M
Gross Margin
AVNT
AVNT
DOC
DOC
Q4 25
30.2%
Q3 25
30.4%
58.6%
Q2 25
32.1%
60.2%
Q1 25
31.8%
61.1%
Q4 24
34.8%
60.3%
Q3 24
32.1%
60.0%
Q2 24
30.3%
60.6%
Q1 24
33.6%
59.8%
Operating Margin
AVNT
AVNT
DOC
DOC
Q4 25
5.2%
17.4%
Q3 25
8.3%
9.2%
Q2 25
11.1%
5.7%
Q1 25
0.1%
7.7%
Q4 24
11.5%
-2.2%
Q3 24
9.5%
14.1%
Q2 24
8.5%
22.3%
Q1 24
11.3%
3.7%
Net Margin
AVNT
AVNT
DOC
DOC
Q4 25
2.2%
73.2%
Q3 25
4.0%
-16.6%
Q2 25
6.1%
4.6%
Q1 25
-2.4%
6.1%
Q4 24
6.5%
0.7%
Q3 24
4.7%
12.3%
Q2 24
4.0%
21.0%
Q1 24
6.0%
1.1%
EPS (diluted)
AVNT
AVNT
DOC
DOC
Q4 25
$0.18
$0.16
Q3 25
$0.36
$-0.17
Q2 25
$0.57
$0.05
Q1 25
$-0.22
$0.06
Q4 24
$0.53
$0.02
Q3 24
$0.41
$0.12
Q2 24
$0.36
$0.21
Q1 24
$0.54
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNT
AVNT
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$1.9B
$9.8B
Stockholders' EquityBook value
$2.4B
$7.5B
Total Assets
$6.0B
$20.3B
Debt / EquityLower = less leverage
0.81×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNT
AVNT
DOC
DOC
Q4 25
$467.5M
Q3 25
$91.0M
Q2 25
$89.4M
Q1 25
$70.6M
Q4 24
$119.8M
Q3 24
$180.4M
Q2 24
$106.9M
Q1 24
$101.8M
Total Debt
AVNT
AVNT
DOC
DOC
Q4 25
$1.9B
$9.8B
Q3 25
$2.0B
$9.1B
Q2 25
$2.0B
$9.0B
Q1 25
$2.1B
$8.9B
Q4 24
$2.1B
$8.7B
Q3 24
$2.1B
$8.6B
Q2 24
$2.1B
$8.6B
Q1 24
$2.1B
$8.8B
Stockholders' Equity
AVNT
AVNT
DOC
DOC
Q4 25
$2.4B
$7.5B
Q3 25
$2.4B
$7.6B
Q2 25
$2.4B
$7.9B
Q1 25
$2.3B
$8.2B
Q4 24
$2.3B
$8.4B
Q3 24
$2.4B
$8.6B
Q2 24
$2.3B
$8.8B
Q1 24
$2.3B
$8.9B
Total Assets
AVNT
AVNT
DOC
DOC
Q4 25
$6.0B
$20.3B
Q3 25
$6.1B
$19.6B
Q2 25
$6.1B
$19.8B
Q1 25
$5.8B
$19.8B
Q4 24
$5.8B
$19.9B
Q3 24
$6.0B
$20.0B
Q2 24
$5.9B
$20.2B
Q1 24
$5.9B
$20.5B
Debt / Equity
AVNT
AVNT
DOC
DOC
Q4 25
0.81×
1.31×
Q3 25
0.83×
1.20×
Q2 25
0.86×
1.14×
Q1 25
0.90×
1.08×
Q4 24
0.89×
1.04×
Q3 24
0.88×
1.00×
Q2 24
0.90×
0.98×
Q1 24
0.90×
0.99×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNT
AVNT
DOC
DOC
Operating Cash FlowLast quarter
$167.8M
$1.3B
Free Cash FlowOCF − Capex
$125.4M
$357.0M
FCF MarginFCF / Revenue
16.5%
49.6%
Capex IntensityCapex / Revenue
5.6%
124.4%
Cash ConversionOCF / Net Profit
9.93×
10.99×
TTM Free Cash FlowTrailing 4 quarters
$195.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNT
AVNT
DOC
DOC
Q4 25
$167.8M
$1.3B
Q3 25
$72.1M
$315.0M
Q2 25
$112.8M
$363.5M
Q1 25
$-51.1M
$279.4M
Q4 24
$122.6M
$1.1B
Q3 24
$71.1M
$318.2M
Q2 24
$105.9M
$316.2M
Q1 24
$-42.8M
$152.6M
Free Cash Flow
AVNT
AVNT
DOC
DOC
Q4 25
$125.4M
$357.0M
Q3 25
$47.4M
Q2 25
$85.8M
Q1 25
$-63.6M
Q4 24
$81.5M
$333.7M
Q3 24
$46.1M
Q2 24
$74.5M
Q1 24
$-67.2M
FCF Margin
AVNT
AVNT
DOC
DOC
Q4 25
16.5%
49.6%
Q3 25
5.9%
Q2 25
9.9%
Q1 25
-7.7%
Q4 24
10.9%
47.8%
Q3 24
5.7%
Q2 24
8.8%
Q1 24
-8.1%
Capex Intensity
AVNT
AVNT
DOC
DOC
Q4 25
5.6%
124.4%
Q3 25
3.1%
Q2 25
3.1%
Q1 25
1.5%
Q4 24
5.5%
105.6%
Q3 24
3.1%
Q2 24
3.7%
Q1 24
2.9%
Cash Conversion
AVNT
AVNT
DOC
DOC
Q4 25
9.93×
10.99×
Q3 25
2.21×
Q2 25
2.14×
11.48×
Q1 25
6.52×
Q4 24
2.54×
235.43×
Q3 24
1.86×
3.71×
Q2 24
3.15×
2.17×
Q1 24
-0.87×
22.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNT
AVNT

Color Additives And Inks$466.0M61%
Specialty Engineered Materials$295.5M39%

DOC
DOC

Segment breakdown not available.

Related Comparisons